ClinicalTrials.gg
WithdrawnNCT01882049Updated May 16, 2016

Use of Adjustable Gastric Band in Adolescents

An interventional study of REALIZE Gastric band (ETHICON) in OBESITY, sponsored by University of Minnesota. Withdrawn at 1 site in United States. Open to participants aged 12 Years to 18 Years. Per ClinicalTrials.gov, last updated 2016-05-16.

Sponsored by University of Minnesota · Not applicable, Interventional, and Treatment

Why this study was withdrawn
study never started due to funding issues
Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Not applicable
Ages
12 Years to 18 Years
Sex
All
01

Study summary

This study is to investigate the use the adjustable gastric band for the treatment of obesity in adolescents.

Read the detailed description

Weight loss is related to the amount of energy or fuel obtained from the kinds and amounts of food eaten. When the amount of exercise and dieting uses less fuel than the amount taken in, the excess is stored as fat. The Adjustable Gastric Band used in this study is a tool to help the participant loose weight along with healthy eating, diet and exercise. This study involves minimally invasive laparoscopic surgery to place the adjustable band around the upper part of the stomach to make a smaller stomach or pouch about the size of a golf ball. One end of the band ends with a flat balloon that goes around the upper part of the stomach. The opening from this small stomach can be changed to allow more or less food into the intestine depending on the amount eaten and the amount of weight lost.

The other end of the of the band ends in a filling port through which saline solution is pumped with a needle through an attached tube to inflate or deflate the balloon. The filling port is attached to the wall of the abdomen under the skin. Because the flow of food is regulated by the band, most people feel full faster. This is how the appetite for food is controlled and the why the person is likely to eat less with the band in place.

Food is digested through the normal digestive process.

02

Conditions studied

  • OBESITY

Browse trials for

03

In context

Obesity

6,570 studies on the registry are indexed under Obesity; 1,718 are open to participants now.

Browse Obesity studies →

Lead sponsor

University of Minnesota is the lead sponsor of 1,210 studies on the registry; 195 are open to participants now.

Of its 133 completed or terminated interventional studies of FDA-regulated products, 92 (69%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

BMI: Female: ≥ 27 - ≥ 33 Male ≥ 26 - ≥ 30.5

Exclusion criteria

Exclusion Criteria:

  • •Hypertension: Systolic blood pressure (SBP) of 140 mm Hg

    • Hyperlipidemia: hyperlipidemia depends on
    • Obstructive Sleep Apnea:
    • Metabolic Syndrom: The presence of any three of the following: abdominal obesity - dimensons for children? triglycerides -cholesterol -
  • fasting glucose
  • blood pressure

    • overweight
    • Non-surgical means of weight reduction failure of
    • Significant psychopathology (absence of ) that could limit the subject's ability to understand the procedure, comply with medical, surgical, and/or behavioral recommendations, as documented during screening assessment;
    • Agrees to refrain from any type of reconstructive surgery that would affect body weight such as abdominal lipoplasty or liposuction, mammoplasty, or removal of excess skin for three years following SAGB placement; and
    • Candidate for surgical weight loss intervention (i.e., meets accepted health criteria for major surgery.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
0 participants (actual)

Study arms

  • Experimental
    Treatment

    Use of Realize gastric band (Ethicon) in adolescents for weight reduction

    Device: REALIZE Gastric band (ETHICON)

Interventions

  • DeviceREALIZE Gastric band (ETHICON)

    Placement of gastric band around upper stomach

06

What researchers measure

Primary outcomes

  1. Weight loss

    Reduction in percent of excess weight loss (%EWL).

    Time frame: Monthly up to one year

07

Study locations

1 site
  • University of Minnesota
    Minneapolis, Minnesota 55414, United States
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of May 2016, a primary completion of May 2016 and a completion of May 2016. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 20, 2012
First posted
Jun 20, 2013
Start
May 2016
Primary completionActual
May 2016
CompletionActual
May 2016
Last update
May 16, 2016
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 16, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01882049
Responsible party
Sponsor
First posted
Jun 20, 2013
Start date
May 2016
Primary completion
May 2016
Completion
May 2016
Last update
May 16, 2016

Study contacts

Sayeed Ikrammudin, MD
principal investigator · University of Minnesota

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in May 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion